State Farm Mutual Automobile Insurance Co. Continues to Hold Position in Becton, Dickinson and Company (NYSE:BDX)

State Farm Mutual Automobile Insurance Co. held its stake in shares of Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent disclosure with the SEC. The firm owned 190,800 shares of the medical instruments supplier’s stock at the end of the first quarter. State Farm Mutual Automobile Insurance Co.’s holdings in Becton, Dickinson and were worth $35,000,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its position in Becton, Dickinson and by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 3,967,843 shares of the medical instruments supplier’s stock worth $727,863,000 after buying an additional 242,081 shares during the last quarter. Wells Fargo & Company MN boosted its position in Becton, Dickinson and by 1.2% in the first quarter. Wells Fargo & Company MN now owns 3,283,068 shares of the medical instruments supplier’s stock worth $602,246,000 after buying an additional 39,362 shares during the last quarter. Fundsmith LLP boosted its position in Becton, Dickinson and by 3.2% in the first quarter. Fundsmith LLP now owns 2,296,613 shares of the medical instruments supplier’s stock worth $421,291,000 after buying an additional 71,691 shares during the last quarter. Mawer Investment Management Ltd. boosted its position in Becton, Dickinson and by 1.3% in the first quarter. Mawer Investment Management Ltd. now owns 1,768,539 shares of the medical instruments supplier’s stock worth $324,418,000 after buying an additional 22,563 shares during the last quarter. Finally, Cantillon Capital Management LLC boosted its position in Becton, Dickinson and by 30.3% in the first quarter. Cantillon Capital Management LLC now owns 1,344,427 shares of the medical instruments supplier’s stock worth $246,622,000 after buying an additional 312,926 shares during the last quarter. Hedge funds and other institutional investors own 75.42% of the company’s stock.

Becton, Dickinson and Company (BDX) opened at 205.30 on Friday. The firm’s 50-day moving average price is $195.21 and its 200-day moving average price is $184.45. Becton, Dickinson and Company has a 52 week low of $161.29 and a 52 week high of $205.73. The stock has a market cap of $43.79 billion, a PE ratio of 34.10 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Tuesday, May 2nd. The medical instruments supplier reported $2.30 EPS for the quarter, beating the consensus estimate of $2.23 by $0.07. Becton, Dickinson and had a return on equity of 25.37% and a net margin of 10.67%. The firm had revenue of $2.97 billion during the quarter, compared to analyst estimates of $2.92 billion. During the same quarter in the prior year, the business posted $2.18 EPS. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. Equities analysts predict that Becton, Dickinson and Company will post $9.45 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 30th. Stockholders of record on Friday, June 9th were issued a dividend of $0.73 per share. The ex-dividend date was Wednesday, June 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.42%. Becton, Dickinson and’s dividend payout ratio is presently 48.26%.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.themarketsdaily.com/2017/07/22/state-farm-mutual-automobile-insurance-co-continues-to-hold-position-in-becton-dickinson-and-company-nysebdx.html.

BDX has been the subject of a number of research analyst reports. Zacks Investment Research cut Becton, Dickinson and from a “buy” rating to a “hold” rating in a research note on Thursday, May 4th. Bank of America Corporation restated a “buy” rating and issued a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Friday. Raymond James Financial, Inc. upgraded Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $210.00 to $180.00 in a research note on Friday, June 30th. Evercore ISI upgraded Becton, Dickinson and from an “in-line” rating to an “outperform” rating and raised their target price for the company from $186.00 to $200.00 in a research note on Monday, April 24th. Finally, BidaskClub upgraded Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $194.69.

In other news, VP Jeffrey S. Sherman sold 28,765 shares of the stock in a transaction on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the sale, the vice president now owns 70,821 shares in the company, valued at approximately $13,171,289.58. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

7 − 3 =